Bandingkan Harga & Kinerja Cipta Sarana Medika Tbk. (DKHH) vs Pyridam Farma Tbk (PYFA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Cipta Sarana Medika Tbk. dan Pyridam Farma Tbk: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Pyridam Farma Tbk diperdagangkan di Rp214 (kapitalisasi pasar 2,29 T, volume 24 jam 16,62 jt). Perbedaan utamanya: Pyridam Farma Tbk jauh lebih besar — sekitar 14,5× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Pyridam Farma Tbk lebih aktif diperdagangkan (16,62 jt vs 8,21 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | PYFA | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 2,29 T |
Volume | 8,21 jt | 16,62 jt |
Lot | 82,15 rb | 166,19 rb |
Perputaran | 515,2 jt | 3,56 M |
Harga Rata-rata | 62,72 | 214,23 |
Nilai Transaksi | 515,2 jt | 3,56 M |
Harga Ekuilibrium Indikatif | 63 | 214 |
Volume Ekuilibrium Indikatif | 1,33 rb | 6,42 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →Tentang Pyridam Farma Tbk
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Selengkapnya di halaman PYFA →
